Home › Compare › BPC-157 vs LL-37
BPC-157 vs LL-37
BPC-157 sits in healing & recovery, while LL-37 sits in immune — so despite being mentioned together they are used for different things. The table below sets out the differences. We give no dosing guidance.
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
BPC-157Healing & Recovery
LL-37ImmuneAt a glance
| BPC-157 | LL-37 | |
|---|---|---|
| Category | Healing & Recovery | Immune |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~30 days | ~30 days |
| Commonly reported effects | Accelerated tissue healing Reduced inflammation Improved gut health Joint pain relief | Broad antimicrobial Wound healing Immune boost |
| Reported considerations | Mild injection site irritation Rare fatigue | Injection site irritation |
The differences that actually matter
They aren't really substitutes: BPC-157 sits in Healing & Recovery while LL-37 sits in Immune. People usually pick between them because of a shared secondary effect rather than because they do the same job.
Where they overlap: accelerated tissue healing.
Reported mainly for BPC-157: reduced inflammation, improved gut health, joint pain relief.
Reported mainly for LL-37: broad antimicrobial, immune boost.
What BPC-157 is
BPC-157 is a stable gastric pentadecapeptide, a sequence of 15 amino acids derived from human gastric juice. Its mechanism of action is complex and multifactorial, not directly targeting a single receptor but rather modulating several physiological pathways involved in tissue repair and protection. Research suggests it influences angiogenesis, the formation of new blood vessels, by interacting with growth factors such as VEGF and FGF-2. It also appears to modulate the nitric oxide system, promoting endothelial nitr
What LL-37 is
LL-37 is a human cathelicidin antimicrobial peptide, a component of the innate immune system. Its mechanism of action involves direct disruption of microbial membranes, providing broad-spectrum antibacterial and antiviral activity. Beyond this direct action, LL-37 acts as a signaling molecule, interacting with various cellular receptors, including G-protein coupled receptors like FPR2, to modulate immune responses. This interaction can influence processes such as chemotaxis, angiogenesis, and cytokine production. B
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — BPC-157 and LL-37 are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between BPC-157 and LL-37?
They aren't really substitutes: BPC-157 sits in Healing & Recovery while LL-37 sits in Immune. People usually pick between them because of a shared secondary effect rather than because they do the same job.
Can you log BPC-157 and LL-37 in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, BPC-157 or LL-37?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.